Navigation Links
Research links 'ecstasy' to survival of key movement-related cells in brain

New research from the University of Cincinnati (UC) suggests that the widely abused club drug "ecstasy," or MDMA, can increase the survival of dopamine cells in the brain during fetal development.

Because these cells are critical in the regulation of voluntary movement, the findings, the researchers say, may lead to better therapies for neurological diseases like Parkinson's.

Led by Jack Lipton, PhD, professor of psychiatry, the study was presented today as an abstract at the Society for Neuroscience annual meeting in Atlanta.

"We're certainly not suggesting that this drug be used to treat diseases," said Lipton. "But finding new methods to enhance the survival of dopamine neurons is critical in developing new drugs for diseases such as Parkinson's.

"While MDMA itself isn't likely to be an appropriate therapy for neurodegenerative diseases, it may provide insights for developing new drugs that have similar properties.

"It's exciting to learn that an abused drug may have potential use for developing new therapeutics," he added. "It really makes you rethink your own preconceptions."

Dopamine is a neurotransmitter that has been found to regulate movement, balance, emotion and motivation, and it also affects pleasurable feelings in the brain. Researchers know that a loss of dopamine cells in the brain leads to the development of Parkinson's disease and possibly other movement disorders. Preventing dopamine cells from dying or aiding in the replacement of those cells is key to finding lasting therapies.

Lipton, director of the developmental neuroscience division in UC's psychiatry department, studies the long-term effects of abused drugs on the developing central nervous system. He noticed, during previous laboratory studies in rats, that prenatal exposure to MDMA increased growth of dopamine cells in the brain. His team then decided to study exposure to MDMA in cultured embryonic cells--where they confirme d that this drug was in fact increasing dopamine cell survival.

The findings, Lipton says, aren't consistent with what is known about adult brains, where MDMA has been shown to cause depletion of neurotransmitters--like dopamine--and has been linked to decreased brain activity.

MDMA, chemically known as methylenedioxymethamphetamine and sold and used illegally as "ecstasy," is a synthetic stimulant that prompts the secretion of large amounts of the neurotransmitters serotonin, dopamine and norepinephrine in the brain. This secretion can lead to prolonged periods of activity, hallucinations and euphoria. Before the United States banned it in 1985, MDMA was tested as a possible adjunct in psychotherapy. In 2001, the FDA agreed to allow MDMA to be tested as a possible treatment for post-traumatic stress disorder.


'"/>

Source:University of Cincinnati


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. Research advances quest for HIV-1 vaccine
6. Research on Worms Yields Clues on Aging
7. Researchers reveal the infectious impact of salmon farms on wild salmon
8. Researchers identify target for cancer drugs
9. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... announce the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The ... is proud to add Target to its list of well-respected retailers. This list ...
(Date:6/23/2016)... , June 23, 2016 Houston Methodist ... the Cy-Fair Sports Association to serve as their ... agreement, Houston Methodist Willowbrook will provide sponsorship support, ... connectivity with association coaches, volunteers, athletes and families. ... the Cy-Fair Sports Association and to bring Houston ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: